Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
INVIBES ADVERTSING [BE0974299316/MLINV]   
[02/10/2017]

INVIBES ADVERTSING : INVIBES TO MEET INSTITUTIONAL INVESTORS DURING THE EUROPEAN LARGE AND MIDCAP EVENT

Paris, 2 October 2017 INVIBES ADVERTISING, an advanced technology company specialized in digital infeed advertising, has announced that it will be taking part in the 17th edition of the European Large & Midcap Event for European listed companies and institutional investors, to be held at the Palais Brongniart conference center in Paris on October 4 & 5, 2017. The two days will be an opportunity... See more
 
D'IETEREN [BE0974259880/DIE]   
[29/09/2017]

D'IETEREN : D’Ieteren pursues its process regarding the potential sale of a minority stake in Belron

PRESS RELEASE: D’IETEREN PURSUES ITS PROCESS REGARDING THE POTENTIAL SALE OF A MINORITY STAKE IN BELRON Friday 29 September 2017 D’Ieteren pursues its process regarding the potential sale of a minority stake in... See more
 
RECTICEL [BE0003656676/REC]   
[29/09/2017]

RECTICEL : CAPITAL INCREASE THROUGH EXERCISE OF WARRANTS

PRESS RELEASE Regulated information Brussels, 29 September 2017 – 18:00 CET Disclosure in accordance with the provisions of the Act of 2 May 2007 CAPITAL INCREASE THROUGH EXERCISE OF WARRANTS Recticel announces that on 29 September 2017 its share capital has been increased following the exercise of i 69,355 warrants of the warrant plan issued... See more
 
D'IETEREN [BE0974259880/DIE]   
[27/09/2017]

D'IETEREN : Repurchase of own shares in the context of the liquidity contract

PRESS RELEASE: REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT REGULATED INFORMATION Wednesday 27 September 2017 – 6:00 pm CET Repurchase of own shares in the context... See more
 
CELYAD [BE0974260896/CYAD]   
[27/09/2017]

CELYAD : Edison issues free strategic overview on future of T-cell therapies for cancer

Edison Investment Research Limited Edison issues free strategic overview on future of Tcell therapies for cancer 27Sep2017 / 15:06 GMT/BST London, UK, 27 September 2017 Edison issues free strategic overview on future of Tcell therapies for cancer The US approval of Novartiss Kymriah for childhood leukaemia opens a dramatic new era of cancer therapy deploying powerful modified white cells CART... See more
 
Gimv [BE0003699130/GIMB]   
[25/09/2017]

Gimv : Gimv is acquiring a majority stake in WEMAS, a leading German provider of passive mobile road safety equipment

Antwerp BE / Gütersloh GE, 25 September 2017, 7:30 CET embargo Gimv is acquiring a majority stake in WEMAS, a leading German provider of passive mobile road safety equipment Along with the management, Gimv is taking over the German WEMAS from NORD Holding, which has held a majority stake since 2011. Gimv is acquiring a significant majority, while the... See more
 
UCB [BE0003739530/UCB]   
[21/09/2017]

UCB : UCB Media Room: Vimpat EU approval for pediatric use

UCB’s antiepileptic drug VIMPAT® lacosamide receives EU approval for paediatric useVIMPAT® is approved for monotherapy and adjunctive therapy of partialonset focal seizures in children aged 4 years and older and now provides a new treatment choice for physicians and their paediatric patients with epilepsy.1Epilepsy is the most common serious neurological disorder among children and young... See more
 
D'IETEREN [BE0974259880/DIE]   
[20/09/2017]

D'IETEREN : Repurchase of own shares in the context of the liquidity contract

PRESS RELEASE: REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT REGULATED INFORMATION Wednesday 20 September 2017 – 6:00 pm CET Repurchase of own shares in the context of... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Currencies
DOLLAR US 17/11 0.8478€ -0.20%
LIVRE STERLING 17/11 1.1187€ -0.23%
FRANC SUISSE 17/11 0.8550€ -0.09%
YEN 17/11 0.0075€ +0.23%

BEL 20 top gainers
UMICORE 18:07 38.500€ +0.35%
DELHAIZE GRO 17:36 102.800€ +0.29%
UMICORE 17:35 75.250€ +0.23%
SOLVAY 17:35 121.050€ +0.04%
D'IETEREN 17:35 38.650€ +0.01%

BEL 20 top losers
KBC 17:35 67.380€ -3.25%
UCB 17:35 61.410€ -2.06%
ELIA 17:35 49.045€ -1.72%
COFINIMMO 17:35 107.450€ -1.33%
TELENET GROU 17:35 58.620€ -1.01%

Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news